共 50 条
- [1] EVALUATION OF MONITORING CRITERIA FOR HIGH-DOSE METHOTREXATE IN CHILDREN WITH ACUTE LYMPHOCYTIC-LEUKEMIA [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1985, 19 (06): : 467 - 467
- [2] HIGH-DOSE METHOTREXATE IN ACUTE LYMPHOCYTIC-LEUKEMIA [J]. CANCER TREATMENT REPORTS, 1977, 61 (04): : 727 - 731
- [3] HIGH-DOSE INTRAVENOUS (IV) METHOTREXATE (MTX) WITH AN INTRATHECAL (IT) MTX BOOST IN THE MAINTENANCE OF ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) IN CHILDREN - A PILOT-STUDY [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 389 - 389
- [6] HIGH DOSE METHOTREXATE (HDM) IN ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 278 - 278
- [7] HIGH-DOSE METHOTREXATE FOR THE REMISSION INDUCTION OF REFRACTORY ADULT ACUTE LYMPHOCYTIC-LEUKEMIA [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1978, 5 : 79 - 84
- [8] HIGH DOSE METHOTREXATE IN ACUTE LYMPHOCYTIC-LEUKEMIA IN CHILDHOOD [J]. ACTA PAEDIATRICA SCANDINAVICA, 1978, 67 (03): : 265 - 268
- [10] TREATMENT OF ACUTE LYMPHOCYTIC LEUKEMIA (ALL) WITH INTERMITTENT HIGH DOSE METHOTREXATE (MTX) AND ASPARAGINASE (A'ASE) [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1974, 15 (MAR): : 182 - 182